Related by context. All words. (Click for frequent words.) 70 NASDAQ CYTK announced 67 Nasdaq IDRA today 65 preclinical efficacy 65 Cytokinetics Incorporated NASDAQ CYTK 64 Nasdaq PCYC 63 Phase Ib II 63 Inc. Nasdaq BNVI 63 Nasdaq IDRA 63 Brentuximab Vedotin SGN 63 #nd EORTC NCI 63 Phase 1a clinical 63 bazedoxifene conjugated estrogens 63 PRNewswire FirstCall Genta Incorporated 63 Nasdaq NPSP 63 trastuzumab DM1 T DM1 62 GetGoal Phase III 62 #th Annual Interscience 62 Corporation Nasdaq GENR 62 CYT# potent vascular disrupting 62 Edge STudy 62 Prostate AdenoCarcinoma Treatment 62 AMEX RGN 62 including eniluracil ADH 62 CRLX# 62 NASDAQ HYTM 62 Nasdaq VICL 62 FOLOTYN ® 62 Nasdaq GNTA 62 R roscovitine 62 NASDAQ CXSP announced 61 BRIM3 61 candidate CRLX# 61 Nasdaq PPHM 61 Inc. NASDAQ HEPH 61 BCIRG 61 phase IIb study 61 Genta Incorporated OTCBB GETA 61 evaluating tivozanib 61 telomerase inhibitor drug 61 #th Interscience Conference 61 Nasdaq OPTR 61 AACR San Antonio 61 CALGB # [002] 61 NYSE Amex PBTH 61 RECORD1 61 Hepatotoxicity 61 Phase III placebo controlled 61 NASDAQ LIPD 61 Nasdaq DVAX 61 ThermoDox ® clinical 61 orally inhaled migraine 61 HCV SPRINT 61 ViroPharma Incorporated Nasdaq VPHM 61 ORAL Sync 61 PORxin TM platforms 61 multicenter Phase III 61 Nasdaq FURX 61 MEND CABG 61 Vion Pharmaceuticals 60 fidaxomicin Phase 3 60 fidaxomicin Phase 60 Inc. Nasdaq VRUS 60 Randomized Phase 60 Inc. Nasdaq BIOD 60 alvespimycin 60 Therapeutic Competitors companiesandmarkets.com adEgemonye 60 clevidipine 60 CIMZIA TM certolizumab pegol 60 NASDAQ INGN 60 Nasdaq PARD 60 Phase III AFFIRM 60 AA Amyloidosis 60 HCV RESPOND 2 60 PreCISe 60 AACR NCI EORTC 60 stage hypoxia activated 60 CHAMPION PCI 60 Nasdaq NPSP announced 60 CTRC AACR San Antonio 60 Matrix Phase 2b 60 Nasdaq NRGN 60 DASISION 60 Nasdaq MAPP 60 Ultrafast Insulin 60 BiTE R 60 APPRAISE 60 NASDAQ ARRY 60 number NCT# ClinicalTrials.gov 60 crizotinib PF # 60 BRIM2 60 forodesine 60 Pivotal Phase III 60 phase IIb clinical 60 Late Breaker 60 AMEX DDD 60 Hedgehog Pathway Inhibitor 60 rhLF 60 Phase IIIb 60 ADVANCE PD 60 IMPACT DCM 60 Meta analyzes 60 RegeneRx Biopharmaceuticals Inc. 60 fosbretabulin 60 Inc. NASDAQ AXYX 60 SUCCEED trial 60 NASDAQ IDRA 60 PRNewswire FirstCall Cytokinetics Incorporated 60 CD# CEA 59 Nasdaq NYMX 59 Nasdaq IMMU 59 Presents Preclinical 59 Completes Patient Enrollment 59 Nasdaq ENZN 59 neratinib 59 ongoing Phase 1b 59 Acute Ischemic Stroke 59 Inc. NASDAQ AVNR 59 BR.# 59 pharmacokinetic PK study 59 PRNewswire FirstCall Bionovo 59 NASDAQ DYAX 59 Reports Preclinical Data 59 Phase Ib clinical 59 SinuNase ™ 59 viral kinetic 59 CROI 59 LUX Lung 59 midstage clinical 59 ExTRACT TIMI 59 LibiGel ® 59 Molecular Cancer 59 AVERROES 59 rALLy clinical trial 59 brivaracetam 59 Proellex TM 59 Society CTOS 59 phase IIIb 59 Solorel TM 59 Nasdaq REGN 59 Nasdaq NFLD announced 59 Triapine R 59 meta regression 59 Nasdaq VRTX 59 transthyretin TTR mediated amyloidosis 59 CAMMS# 59 INxin TM 59 prospective multicentre 59 NASDAQ ABII 59 PERSEUS 59 ASH Annual Meeting 59 sodium thiosulfate STS 59 Opportunistic Infections CROI 59 PRNewswire FirstCall YM BioSciences 59 Inc. Nasdaq AVRX 58 CUSTOM II 58 evaluating mipomersen 58 USpella 58 PROSTVAC TM 58 Xelox 58 EVEREST II 58 clinical pharmacology studies 58 ASCO GU 58 OTCBB INSV 58 MERLIN TIMI 58 Nasdaq ACHN 58 Inc. NASDAQ BPAX 58 ICAAC IDSA 58 evaluating REVLIMID 58 Inc. NASDAQ NBIX 58 www.givenimaging.com 58 ZACTIMA 58 NASDAQ ARIA 58 novel VDA molecule 58 ID NCT# 58 XL# SAR# 58 SinuNase TM 58 Phase IIIB IV 58 NSABP B 58 TG MV 58 Inc. Nasdaq SGEN 58 Inc. Nasdaq ATHX 58 Preclinical Study 58 davunetide intranasal AL 58 TSX PLI ProMetic 58 REVIVE TA 58 Therapeutics TCT scientific 58 OTCBB CVBT 58 ECTRIMS 58 IMPROVE HF 58 TLR antagonists 58 Initiate Phase 58 NASDAQ NYMX 58 Inc. Nasdaq NSTK 58 Incorporated NASDAQ PFWD 58 OTCBB EMIS 58 ABCSG 58 PRNewswire FirstCall Pharmasset 58 seliciclib CYC# 58 America HFSA 58 AVADO 58 Phase III Pivotal 58 multicenter Phase II 58 PRNewswire FirstCall Cell Genesys 58 Inc. NASDAQ ACUS 58 relapsed MM 58 ON #.Na 58 NASDAQ HLCS 58 LibiGel Phase III 58 recurrent glioblastoma multiforme 58 Clinicaltrials.gov 58 SABCS 58 Nasdaq OSIP 58 cisplatin gemcitabine 58 Rheumatology ACR Annual 58 Nasdaq INGN 58 Inc. Nasdaq MDVN 58 REGENERX BIOPHARMACEUTICALS INC. 58 Hepatocellular Carcinoma HCC 58 OTCBB AOLS 58 assessing T DM1 58 CTAP# Capsules 58 placebo controlled Phase III 58 Amex ANX 58 CRMD# 58 radezolid 58 acetonide FA 58 Androxal TM 58 trastuzumab emtansine T DM1 58 AACR #st Annual Meeting 58 CLARITY study 58 perifosine KRX 58 TSX BLU 58 MAGE A3 ASCI 58 phase Ib 58 RGB # 58 NASDAQ INHX 58 TAXUS ATLAS 58 Cloretazine R 58 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 58 preclinical pharmacokinetic 58 NO# [002] 58 Inc. Nasdaq OPTR 58 NASDAQ CLDX 58 Vascugel ® 58 phase IIa clinical 58 Initiated Phase 58 NASDAQ NMS DUSA 58 EXPAREL ™ 58 Nasdaq CBST 58 Nasdaq ALXN 58 Inc. TSX ONC 58 TSX DND 58 galiximab 58 Announces Poster Presentations 58 Inc. Nasdaq EXEL 58 LungAlert TM 57 LymphoStat B TM 57 NASDAQ OGXI 57 Sangamo BioSciences Announces 57 NCCTG N# 57 oral FTY# 57 Preclinical Data 57 Pre RELAX AHF 57 Phase III ADT 57 NASDAQ PCYC 57 NASDAQ BMTI 57 www.ClinicalTrials.gov 57 Nasdaq SNSS 57 ChemGenex Pharmaceuticals Limited 57 riociguat 57 NASDAQ TARG 57 Inc. Nasdaq TELK 57 Inc. NASDAQ SNUS 57 ASCO GI 57 prospective observational studies 57 multicenter placebo controlled 57 sNDA submission 57 REMINYL ® 57 Phase 2a clinical 57 Topline Results 57 budesonide MMX Phase III 57 Presents Positive Preclinical 57 NEUVENGE 57 Bayer HealthCare Onyx Pharmaceuticals 57 kidney urologic 57 PHASE III 57 Inc. Nasdaq ALXA 57 Phase Ib study 57 LibiGel testosterone gel 57 Biological Therapy 57 Pooled Analysis 57 Inc. Nasdaq TRCA 57 AIR2 Trial 57 Exherin TM 57 TÎ ² 4 57 genitourinary cancers 57 CARE HF 57 NASDAQ SLXP today 57 Renal Cell Carcinoma RCC 57 ALN PCS 57 PSMA ADC 57 Combination REOLYSIN R 57 Alternext ALEHT 57 NASDAQ ONCY 57 #rd Annual CTRC 57 Nasdaq DNDN 57 IMPACT IMmunotherapy 57 HORIZONS AMI 57 Sorafenib HCC Assessment 57 PRNewswire FirstCall MannKind 57 PLK1 SNALP 57 BiTE antibody MT# 57 Immunotherapeutic 57 Dacogen injection 57 PRNewswire FirstCall VIVUS 57 ENDEAVOR III 57 Digital Mammographic Imaging 57 immunoregulation 57 multicenter trials 57 HuMax EGFr 57 Evaluation WISE 57 HCV NS5B polymerase 57 Chronic Lymphocytic Leukemia CLL 57 GVAX ® 57 AASLD Meeting 57 Randomized Double Blind Placebo 57 Antisoma AS# 57 Novel Oral 57 Intervention Trial GAIT 57 multicenter randomized placebo controlled 57 SYMMETRY trial 57 Nasdaq CYCC Nasdaq CYCCP 57 gastrointestinal malignancies 57 SoftScan ® 57 recurrent malignant glioma 57 EGS# 57 MGd 57 NASDAQ OSIP announced 57 OTCBB PYTO 57 Ltd. NASDAQ GIVN 57 NASDAQ AVNR 57 elotuzumab 57 multicenter Phase 57 Adult Stem Cell Therapy 57 secretory phospholipase A2 sPLA2 57 Ceflatonin R 57 BOLDER II 57 inhalation toxicology 57 TSX SHQ 57 ILLUMINATE 57 Nasdaq GENR 57 HDL Selective Delipidation 57 Inc. Nasdaq ACOR 57 MOZOBIL 57 Inc. Nasdaq GHDX 57 Zenvia Phase III 57 BCLI 57 PRECISE trial 57 randomized controlled Phase 57 www.vivus.com 57 Pivotal Phase 57 Inc. Nasdaq INFI 57 Abstract Accepted 57 Connective Tissue Oncology 57 www.telik.com 56 Trofex 56 placebo controlled clinical 56 Phase III ALLEGRO 56 P#X# antagonist 56 LHRH receptor positive 56 NYSE Amex ULU 56 Guanilib 56 vinca alkaloid 56 Ophena TM 56 vidofludimus 56 NASDAQ ISTA 56 Aplidin R 56 randomized Phase 2b 56 Initiates Clinical Trial 56 ELACYT 56 preclinical pharmacology 56 Pemphigus Vulgaris 56 TQT studies 56 Prodarsan R 56 sunitinib malate 56 Randomized Double blind 56 Presents Positive 56 LSE SHP NASDAQ SHPGY 56 Naurex 56 PDX pralatrexate 56 Xcytrin R 56 NASDAQ AMAG 56 Diabetologia 56 Entereg R 56 Testosterone MDTS ® 56 Inc. NASDAQ AGIX 56 Quinamed 56 ASCO Breast Cancer 56 Glufosfamide 56 Phase Ib clinical trials 56 ASBMR 56 PhG alpha 1 56 http:/www.vivus.com 56 ALN TTR 56 Oral Fingolimod 56 Val HeFT 56 EXPLORE Xa 56 Systemic Sclerosis 56 PEG SN# 56 demonstrated antitumor activity 56 Prospective Randomized 56 NABTT 56 trodusquemine 56 randomized discontinuation trial 56 midstage trials 56 Semafore Pharmaceuticals 56 Inc. NASDAQ SGEN 56 www.labopharm.com 56 ANN INTERN MED 56 ONCONASE R 56 Nasdaq EMIS 56 Myelodysplastic syndromes MDS 56 Urocortin 2 56 histone deacetylase HDAC inhibitor 56 EGFR HER2 56 NYSE Amex RGN 56 www.micromet inc.com 56 PANVAC VF 56 ONCOLOGY 56 Nasdaq MBRX announced 56 ZYBRESTAT fosbretabulin 56 MGN# 56 Intervention Effectiveness 56 ongoing Phase IIIb 56 NASDAQ OSIR 56 Phase 2b Clinical Trial 56 MBRX 56 worsening thrombocytopenia 56 ATAC Arimidex Tamoxifen Alone 56 delafloxacin 56 Cholesterol Levels SPARCL 56 Nasdaq ISTA 56 Clinical Oncology Annual Meeting 56 PROactive Study 56 Phase III Clinical Trials 56 Phase 1b clinical trials 56 Nasdaq OMER 56 Inc. NASDAQ ALTH 56 neurotherapeutics 56 CR# vcMMAE 56 ganetespib 56 Lauren Silvernail 56 trastuzumab DM1 56 ThermoDox R 56 depsipeptide 56 BRAF inhibitor 56 Inc. Nasdaq IMGN 56 TRA 2P 56 Epidemiological Studies Unit 56 varespladib 56 CEQ# 56 evaluating Prochymal 56 R#/MEM 56 NYSE Alternext ULU 56 NASDAQ BPAX 56 Nasdaq EXAS 56 AMPAKINE CX# 56 ABI OTCBB AMAR 56 thorough QT 56 THALOMID 56 Aflibercept 56 Evoltra ® 56 ALN VSP 56 Cloretazine ® 56 OXi# 56 NASDAQ ALTH 56 opioid induced bowel dysfunction 56 SPIRIT FIRST 56 Nasdaq IDIX 56 Biodesix 56 www.ecri.org 56 tanespimycin 56 Transcatheter Cardiovascular Therapeutics TCT 56 Brussels THR 56 Pyridorin 56 pharmacokinetic pharmacodynamic 56 mg administered orally 56 ZFP Therapeutic 56 Inc. Nasdaq SEPR 56 DDW ® 56 INS# [001] 56 postoperative ileus POI 56 Phase IIb III 56 non nucleoside inhibitor 56 Gynecologic Oncology Group 56 Inc. Nasdaq SGMO 56 please visit www.brighamandwomens.org 56 oral prodrug 56 PHX# 56 Cloretazine 56 GLOBE NEWSWIRE Icagen 56 isatoribine 56 teriflunomide 56 Poster Presentations 56 Phase IIA 56 PRNewswire FirstCall Anesiva 56 Clinical Trial Data 56 angiographic outcomes 56 http:/www.unigene.com 56 JAK2 Inhibitor 56 Nasdaq MITI biopharmaceutical 56 BiTE antibodies targeting 56 Nasdaq AVNR 56 selective androgen receptor modulator 56 EORTC NCI 56 Orqis Medical 56 acyclovir Lauriad R 56 PRE SURGE 56 lexidronam injection 56 Phase #b/#a clinical 56 www.asco.org 56 TSX TKM 56 AMEX INO 56 Nasdaq ONXX today 56 rALLy trial 56 AZX# 56 EURIDIS 56 treatment naive genotype 56 www.oncogenex.com 56 vaginally administered lidocaine 56 Successfully Completes Phase 56 cediranib 56 please visit www.metabolon.com 56 non nucleoside HCV 56 TransVax TM 56 MEND CABG II 56 Nexavar sorafenib 56 Arch Neurol 56 ACUITY trial 56 oral methylnaltrexone 56 Inotek Pharmaceuticals Corporation 55 Nasdaq SGMO announced 55 Inc. NASDAQ MIPI 55 YONDELIS 55 GRN# 55 Aryplase 55 ancrod 55 Inc. Nasdaq DCTH 55 biostatistical analysis 55 CUSTOM III 55 Prolongs Survival 55 Breaking Clinical Trials 55 http:/www.vical.com 55 UEGW 55 Tesmilifene 55 PFO migraine 55 Phase #/#a 55 Cleviprex TM clevidipine 55 pain palliation 55 HORIZONS AMI trial 55 EORTC NCI AACR Symposium 55 Arimidex anastrozole 55 alpha antagonist 55 Testosterone MDTS R 55 Phase III psoriasis 55 genomic biomarker 55 phase III ACCLAIM 55 branch RVO 55 Multiple Ascending Dose 55 randomized Phase IIb 55 pivotal bioequivalence 55 Inc. AMEX YMI 55 GW# [003] 55 Initiates Phase III 55 phase IIb III 55 AASLD 55 Stent Thrombosis 55 MCSP respectively 55 constipation OIC 55 vapreotide acetate 55 EORTC NCI AACR 55 Cardiotoxicity 55 OTCBB UPBS 55 management biostatistical analysis 55 LSE ASM 55 Phase IIIb clinical 55 glufosfamide 55 pharmacokinetic PK 55 Celsion Corporation 55 GLOBE NEWSWIRE Emisphere Technologies 55 ASGCT 55 velafermin 55 NYSE Amex PTN 55 ophthalmic therapeutics 55 annual Transcatheter Cardiovascular 55 Inc. Nasdaq CPRX 55 PROSTVAC VF 55 See CLINICAL PHARMACOLOGY 55 bardoxolone methyl 55 satraplatin Phase 55 OTCQX RHHBY 55 antisense inhibitors 55 TBC# 55 Immunomedics Announces 55 Breast Cancer Symposium SABCS 55 TRACON Pharmaceuticals 55 Aplidin 55 registrational Phase 55 NP2 Enkephalin 55 TASKi2 55 YM AIM YMBA 55 predictive toxicology 55 Current Controlled Trials 55 EDEMA3 55 Deforolimus 55 Initiates Phase II 55 Randomized Phase III 55 Inc. Nasdaq ONTY 55 DAPT Study 55 NEVO RES 55 Pluristem Therapeutics 55 Medical Oncology ESMO 55 Nuvelo Announces 55 sorafenib tablets 55 TRANSFORMS 55 JAK2 inhibitor 55 alvimopan 55 GLP toxicology studies 55 Phase 2b RESTORE CLI 55 NYSE Amex YMI TSX 55 Phase 2a clinical trials 55 NASDAQ EPIX 55 CONBRIZA 55 Raptiva R 55 Corporation Nasdaq MNKD 55 Nonclinical 55 By JENNIFER LEARN 55 Nymox NX 55 entinostat 55 DAS# Fludase ® 55 Vical Incorporated Nasdaq VICL 55 agalsidase alfa 55 Screening Trial DMIST 55 lorcaserin Phase 55 cannabinor 55 Nasdaq CLDX 55 Curon Medical 55 INSPIRE Trial Phase III 55 GRNVAC1 55 Corporation Nasdaq CRGN 55 BACcel ™ system 55 GEM OS2 55 Prostate Disease 55 Calcium Acetate 55 Nasdaq DARA 55 TELINTRA 55 SUTENT ® 55 histone deacetylase inhibitor 55 Inc. Nasdaq MLNM 55 Therapeutics TCT 55 Inc. Nasdaq ALTH 55 FDA Approvable Letter 55 essential thrombocythemia ET 55 Genitourinary Cancers Symposium 55 pharmacogenomic translational research 55 mertansine 55 enzastaurin 55 Inc. NASDAQ BIOC 55 IL# PE#QQR 55 please visit www.advaxis.com 55 CIPN 55 HCV polymerase inhibitors 55 Compugen NASDAQ CGEN 55 Nasdaq TARG 55 Podium Presentation 55 Insmed Incorporated NASDAQ INSM 55 AAG geldanamycin analog 55 Phase IIa clinical 55 cystinosis patients 55 Truvada tablets 55 Hematologic 55 Vaccine Immunology 55 Zemiva TM 55 Inc. Nasdaq CRTX 55 Company TSX WXI 55 PRNewswire FirstCall Nastech Pharmaceutical 55 Phase Ib Clinical Trial 55 bepotastine besilate nasal spray 55 eTag assays 55 NSABP 55 ENDEAVOR IV 55 standard chemotherapy regimen 55 Metastatic Melanoma 55 ospemifene 55 Phase 2b clinical 55 PROactive study 55 cabozantinib 55 www.cancerconsultants.com 55 CINTREDEKIN BESUDOTOX 55 PINKSHEETS KKUR 55 HeFH 55 Cerus Corporation NASDAQ CERS 55 ticagrelor Brilinta 55 Hedgehog antagonist 55 Hsp# Inhibitor 55 PEARL HF 55 prelicensure 55 EECP R 55 Nymox Pharmaceutical Corporation 55 OHR/AVR# 55 TLK# 55 TNFerade TM 55 Telik logo TELINTRA 55 Mesoblast Limited ASX MSB 55 anastrozole Arimidex 55 Aphton Corporation 55 NASDAQ AEZS 55 Maven Semantic http:/www.mavensemantic.com announBruising Brandon 55 Preclinical Efficacy 55 brivanib 55 Canaccord Adams Hepatitis C 55 lumiliximab 55 compound AEZS 55 SPIRIT IV 55 pan HDAC inhibitor 55 Fabry Disease 55 Actimmune ® 55 TB4 mechanisms 55 placebo controlled clinical trials 55 Amrubicin 55 RNA interference RNAi therapeutics 55 http:/www.curagen.com 55 Cancer Incidence Mortality 55 Vaccine Adjuvant 55 Genta Incorporated OTCBB 55 Maven Semantic 55 GATTEX TM 55 ENESTnd 55 randomized controlled multicenter 55 JAK inhibitor 55 Achieves Primary Endpoint 55 BARI 2D 55 microplasmin Phase III 55 Initiates Enrollment 55 Oncology ASTRO 55 Elagolix 55 nonclinical studies 55 Marrow Transplant Research 55 Nasdaq MITI 55 Zenvia ™ 55 Vidaza azacitidine 55 journal Anesthesia 55 NEUGENE R 54 journal Ophthalmology 54 Outpatient Setting 54 dose escalation clinical 54 Presents Preclinical Data 54 Predictive medicine 54 MabThera rituximab 54 SNT MC# 54 Endovascular Valve Edge 54 Azedra 54 Sunesis Pharmaceuticals Inc. 54 GATTEX ® 54 Phase 1b trial 54 APEX AMI trial 54 Nasdaq VRTX today 54 HepaMate 54 Tß4 54 www.pranabio.com 54 Nasdaq DCGN 54 oral ridaforolimus 54 Diabetic Neuropathy 54 First Patient Enrolled 54 ostarine 54 vascular disrupting agent 54 aripiprazole Abilify 54 Oral Insulin Capsule 54 purinergic receptors P#X# 54 personalized dendritic cell 54 bicifadine 54 Protein Expression 54 NASDAQ OPTR 54 ISPOR 54 GRNCM1 54 huC# DM4 54 Hana Biosciences 54 TSX COM 54 blood serum biomarkers 54 PSN# [002] 54 Inc. Nasdaq VSCP 54 Virulizin ® 54 AEG# 54 prospective longitudinal 54 ASCO Annual Meeting 54 HCD# [002] 54 ALN TTR# 54 Phase III Clinical Trial 54 www.durect.com 54 phase IIa 54 AIM OBP 54 Myocet 54 Phase 2b monotherapy 54 Rhucin ® recombinant 54 II Clinical Trial 54 Stem Cell Research ISSCR 54 recurrent glioma 54 Tumor Response 54 NCCTG 54 PRNewswire FirstCall Poniard Pharmaceuticals 54 APOPTONE 54 Neoplasia 54 GLOBOCAN 54 Pharmacodynamic 54 OTC BB PVCT 54 Ocrelizumab 54 NGNM 54 sipuleucel T 54 ACOSOG Z# 54 INTERCEPT platelets 54 p# inhibitor 54 NYSE Amex YMI 54 endometriosis ovarian cysts 54 desvenlafaxine succinate 54 Phase 1b clinical 54 PCI ExTRACT TIMI 54 haematologic 54 oral JAK1 54 Nasdaq ACEL 54 NASDAQ TGEN 54 Nasdaq RGEN 54 prospective nonrandomized 54 Phase 1b 54 lorvotuzumab mertansine 54 phase IIb trial 54 Inc. Nasdaq DSCO 54 ALN HPN 54 Cardiometabolic 54 Nasdaq TRCA 54 Phase III multicenter 54 CALGB 54 TSX VENTURE SVA 54 YONDELIS R 54 dbGaP 54 CaPre TM 54 RE LY ® 54 www.nextrials.com 54 Tectin TM 54 programs visit http:/www.bionovo.com 54 PORxin TM 54 EuroIntervention 54 phase IIb 54 multicenter multinational 54 Gynecologic Cancer Society 54 AVN# Phase 54 PRNewswire FirstCall CEL SCI 54 TAXUS IV 54 identifier NCT# 54 Kahalalide F 54 Romidepsin 54 please visit http:/www.sunesis.com 54 HCV Protease Inhibitor 54 cardio renal 54 deforolimus 54 #-# PMID # 54 www.vicortech.com 54 Antiviral Activity 54 Liprotamase 54 Carotid Stenting 54 TMC# C# 54 Lipid Sciences Inc. 54 Pharmacokinetics PK 54 PRNewswire FirstCall Kensey Nash 54 VEITHsymposium 54 CATIE AD 54 placebo controlled studies 54 Unstable Angina 54 PROTECT II 54 PROVENGE ® 54 glucocorticoid induced osteoporosis 54 PRNewswire FirstCall NicOx SA 54 ONCY 54 Demonstrates Sustained 54 Drug Eluting Stent System 54 Ohr Pharmaceutical Inc. 54 www.cerus.com 54 ENDO 54 Temsirolimus 54 adecatumumab 54 controlled multicenter Phase 54 Zemplar Capsules 54 Nasdaq IDIX biopharmaceutical 54 OZURDEX ® 54 REVIVE Diabetes 54 viral kinetics 54 DermTech International 54 Lorus Therapeutics 54 Outcome Sciences 54 Phase 2b randomized 54 PRNewswire FirstCall Monogram Biosciences 54 Carotid Revascularization Endarterectomy vs. 54 IMiDs ® compound 54 Initiates Phase 2b 54 Alocrest 54 BioSante LibiGel Phase III 54 Multicenter 54 Arteriosclerosis Thrombosis 54 prospective multicenter study 54 PRNewswire FirstCall VirtualScopics 54 #:#-# [033] 54 www.syntapharma.com 54 & LSE GLPG 54 balsalazide tablet 54 PDE# inhibitors 54 discussed NuroPro Power3 54 meta analysis pooling 54 Circulation Heart Failure 54 visit www.dobimedical.com 54 Psycho Oncology 54 Cimzia ® certolizumab pegol 54 Power3 Alzheimer disease 54 liposomal formulation 54 Severe Sepsis 54 fostamatinib 54 liposome injection 54 PC DAC Exendin 54 Am J Epidemiol 54 Phase IIB clinical 54 ICON7 54 Antisoma plc 54 Gastrointestinal Cancers Symposium 54 Solid Tumors 54 EDEMA3 trial 54 dirucotide MBP# 54 Breast Cancer Symposium 54 ACADIA maintains 54 BrachySil TM 54 Left Ventricular Dysfunction 54 PRIMO CABG 54 Inc. Nasdaq NEOL 54 Therapeutic Advances 54 TACI Ig 54 ADVEXIN therapy 54 Rheumatology Annual 54 refractory chronic lymphocytic 54 www.adeonapharma.com 54 Triapine 54 CCR5 mAb 54 vivo preclinical 54 Clinical Antipsychotic Trials 54 Initiates Clinical 54 ToGA 54 ADVEXIN clinical 54 vitro ADME 54 www.rxipharma.com 54 nonhuman primate model 54 OTCBB BIPH developer 54 mean ± SEM 54 Pivotal Clinical Trial 54 interstitial cystitis IC 54 Chemokine Therapeutics 54 Chicago Multidisciplinary Symposium 54 Catena ® 54 PRNewswire FirstCall Pressure BioSciences 54 miRview meso 54 lomitapide 54 CTI Nasdaq 54 anti CD# antibodies 54 Cancers Symposium 54 PRNewswire FirstCall Allos Therapeutics 54 Potent Antiviral Activity 54 Stent Restenosis 54 BETAS 54 CBLC# 54 MelaFind R 54 Human Mutation 54 CLARITY TIMI 54 Hormone Refractory Prostate Cancer 54 multicenter clinical trials 54 Trandolapril 54 Cytogenetic 54 Panzem ® 54 ANCHOR trial 54 journal Antimicrobial Agents 54 alemtuzumab Campath 54 Placebo Controlled Trial 54 Epeius Biotechnologies Corporation 54 Double Blind Placebo 54 Nasdaq BNVI 54 GAMMAGARD 54 Meets Primary Endpoint 54 Nasdaq CYTR biopharmaceutical 54 Board TBIO 54 NovaBay Aganocide compounds 54 catheter occlusion 54 Interventions SCAI 54 Pediatric Academic Societies PAS 54 Cambridge Healthtech Institute 54 PloS ONE